RCM Opens an Engineering Center of Excellence in Buffalo, New York
Nov 13, 2017 21:05 pm UTC| Business
PENNSAUKEN, N.J., Nov. 13, 2017 -- RCM Technologies, Inc. (Nasdaq:RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the...
Acer Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update
Nov 13, 2017 21:05 pm UTC| Business
Closed Merger and Concurrent $15.7M Financing Announced Positive Results from Pivotal Clinical Trial of EDSIVO™ (celiprolol) forTreatment of vEDS CAMBRIDGE, Mass., Nov. 13, 2017 -- Acer Therapeutics Inc....
Apellis Pharmaceuticals Announces Closing of its Initial Public Offering
Nov 13, 2017 21:05 pm UTC| Business
CRESTWOOD, Ky., Nov. 13, 2017 -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition...
Everi Completes Repricing of $820 Million Term Loan Facility
Nov 13, 2017 21:05 pm UTC| Business
LAS VEGAS, Nov. 13, 2017 -- Everi Holdings Inc. (NYSE:EVRI) (“Everi” or the “Company”), the casino gaming industry’s single source provider of gaming products and payments solutions, announced today that it has...
BeiGene Expands Global Pivotal Program for BTK Inhibitor BGB-3111
Nov 13, 2017 21:05 pm UTC| Business
Initiates global Phase 3 trial of BGB-3111 compared to bendamustine and rituximab (BR) in treatment-naïve chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL) patientsInitiates global pivotal Phase 2 trial...
Nov 13, 2017 21:05 pm UTC| Business
SAN DIEGO, Nov. 13, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Everspin Adds Semiconductor Veteran as new Vice President of Operations
Nov 13, 2017 21:05 pm UTC| Business
CHANDLER, Ariz., Nov. 13, 2017 -- Everspin Technologies, Inc., (Nasdaq:MRAM), today announced the appointment of Norm Armour as Vice President of Operations, responsible for managing Everspin’s captive and partner fab...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update